BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25133418)

  • 21. Immune-mediated inner ear disease.
    Bovo R; Aimoni C; Martini A
    Acta Otolaryngol; 2006 Oct; 126(10):1012-21. PubMed ID: 16923703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss.
    Banerjee A; Parnes LS
    Otol Neurotol; 2005 Sep; 26(5):878-81. PubMed ID: 16151332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application.
    Parnes LS; Sun AH; Freeman DJ
    Laryngoscope; 1999 Jul; 109(7 Pt 2):1-17. PubMed ID: 10399889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune-mediated inner ear disease and parvovirus B19.
    Cotter CS; Singleton GT; Corman LC
    Laryngoscope; 1994 Oct; 104(10):1235-9. PubMed ID: 7934594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical versus theoretical management of autoimmune inner ear disease.
    Hughes GB; Kinney SE; Barna BP; Calabrese LH
    Laryngoscope; 1984 Jun; 94(6):758-67. PubMed ID: 6374341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric fluctuating sensorineural hearing loss: problems in medical management.
    Dinces EA; Yang S; Balogun AO
    Laryngoscope; 2001 Jan; 111(1):21-5. PubMed ID: 11192894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial.
    Rauch SD; Halpin CF; Antonelli PJ; Babu S; Carey JP; Gantz BJ; Goebel JA; Hammerschlag PE; Harris JP; Isaacson B; Lee D; Linstrom CJ; Parnes LS; Shi H; Slattery WH; Telian SA; Vrabec JT; Reda DJ
    JAMA; 2011 May; 305(20):2071-9. PubMed ID: 21610239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The utility of positron emission tomography in the evaluation of autoimmune hearing loss.
    Mazlumzadeh M; Lowe VJ; Mullan BP; Fabry DA; McDonald TJ; Matteson EL
    Otol Neurotol; 2003 Mar; 24(2):201-4. PubMed ID: 12621332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity of the Western blot immunoassay for heat shock protein-70 in associated and isolated immunorelated inner ear disease.
    García Berrocal JR; Ramírez-Camacho R; Arellano B; Vargas JA
    Laryngoscope; 2002 Feb; 112(2):304-9. PubMed ID: 11889388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial audiometry in a clinical trial of AIED treatment.
    Niparko JK; Wang NY; Rauch SD; Russell GB; Espeland MA; Pierce JJ; Bowditch S; Masuda A; Gulya AJ; Gantz BJ; Hughes GB; Brookhouser PE; Hannley MT; Telian SA; Harris JP;
    Otol Neurotol; 2005 Sep; 26(5):908-17. PubMed ID: 16151337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cochleo-vestibular lesions and prognosis in patients with profound sudden sensorineural hearing loss: a comparative analysis].
    Wu X; Liu M; Zhuang HW; Chen KT; Yang ZY; Xiong GX
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):472-478. PubMed ID: 32842361
    [No Abstract]   [Full Text] [Related]  

  • 32. Sudden sensorineural hearing loss: supporting the immunologic theory.
    Berrocal JR; Ramírez-Camacho R
    Ann Otol Rhinol Laryngol; 2002 Nov; 111(11):989-97. PubMed ID: 12450172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral Sudden Sensorineural Hearing Loss and Intralabyrinthine Hemorrhage in a Patient With COVID-19.
    Chern A; Famuyide AO; Moonis G; Lalwani AK
    Otol Neurotol; 2021 Jan; 42(1):e10-e14. PubMed ID: 33301283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.
    Van Wijk F; Staecker H; Keithley E; Lefebvre PP
    Audiol Neurootol; 2006; 11(6):357-65. PubMed ID: 16988499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute bilateral sensorineural hearing loss caused by immuno-mediated inner ear disease].
    Abbate A; Viaggio MB; Piras D; López L; Hubscher O; Nogués M
    Medicina (B Aires); 2001; 61(6):860-2. PubMed ID: 11808429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unusual and instructive case of immune-mediated inner ear disease associated with central nervous system vasculitis.
    Ruckenstein MJ; McKown KM; Jacewicz M
    Otolaryngol Head Neck Surg; 2000 Jan; 122(1):109-11. PubMed ID: 10629494
    [No Abstract]   [Full Text] [Related]  

  • 37. Inner ear and retrocochlear pathology on magnetic resonance imaging for sudden and progressive asymmetrical sensorineural hearing loss.
    Baird SM; Nguyen K; Bhatia DDS; Wei BPC
    ANZ J Surg; 2019 Jun; 89(6):738-742. PubMed ID: 30497101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on autoimmune inner ear disease: A systematic review of pharmacotherapy.
    Strum D; Kim S; Shim T; Monfared A
    Am J Otolaryngol; 2020; 41(1):102310. PubMed ID: 31733712
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnostic and therapeutic dilemmas in rapidly progressive sensorineural hearing loss and sudden deafness. A reappraisal of immune reactivity in inner ear disorders.
    Veldman JE; Hanada T; Meeuwsen F
    Acta Otolaryngol; 1993 May; 113(3):303-6. PubMed ID: 7685975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute low tone sensorineural hearing loss caused by inner ear barotrauma].
    Abe T; Sasamori S; Oikawa T; Aigami T; Endo Y; Matsuki C
    Nihon Jibiinkoka Gakkai Kaiho; 1989 Sep; 92(9):1381-8. PubMed ID: 2585206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.